Aerosol therapy in cystic fibrosis: A national survey;Aerosoltherapie et mucoviscidose: Enquete nationale

Revue de Pneumologie Clinique

Volumn 53, Issue 2, 1997, Pages 91-97

  Huet, F ^a   Nivelon, J L ^a  

^a Medical University of Dijon   (France)

Author keywords

aerosol therapy; cystic fibrosis

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CEFTAZIDIME; DEOXYRIBONUCLEASE; NEOMYCIN; TOBRAMYCIN;

ARTICLE; CLINICAL TRIAL; CYSTIC FIBROSIS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; PSEUDOMONAS AERUGINOSA; QUESTIONNAIRE; AEROSOL; MULTICENTER STUDY; REVIEW;

ADMINISTRATION, INHALATION; AEROSOLS; CYSTIC FIBROSIS; HUMANS; QUESTIONNAIRES;

EID: 0030913674     PISSN: 00325821     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Fiel S.B., Fitzsimmons S., Schildlow D. : Evolving demographics of cystic fibrosis. Sem. Resp. Crit. Care. Med., 1994, 15 : 349-55.
2. Mearns M.B. : Aerosol therapy in cystic fibrosis. Arch. Dis. Child., 1970, 45 : 605-7.
3. Hodson M.E., Penketh A.R.L., Batten J.C. : Aerosol carbenicillin and gentamicin treatment of pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet. 1981, ii : 1137-9.
4. Silly C., Lenoir G., Navarro J. : Thérapeutiques inhalées au cours de la mucoviscidose, in : Flammarion Médecine-Sciences : Journées Parisiennes de Pédiatrie, Paris, 1992, pp.87-93.
5. Mac Lusky I., Levison H., Gold R., Mac Laughlin F.J. : Inhaled antibiotics in cystic fibrosis : is there a therapeutic effect ? J. Pediatr., 1986, 108 : 861-5.
6. Fiel S.B. : Aerosol delivery of antibiotics to the lower airways of patients with cystic fibrosis. Chest, 1995, 107 : 61S-64S.
7. Littlewood J.M., Smye S.W., Cunliffe H. : Aerosol antibiotic treatment in cystic fibrosis. Arch. Dis. Child., 1993, 68 : 788-92.
8. Harris C.E., Wilmott R.W. : Inhalation-based therapies in the treatment of cystic fibrosis. Cur. Opinion Pediatr., 1994, 6 : 234-8
9. Hodson M.E. : Antibiotic treatment aerosol therapy. Chest, 1988, 94 : 156S-160S.
10. Amin N., Dozor A.J. : Effects of administration of aerosolized recombinant human deoxyribonuclease on resting energy expenditure in patients with cystic fibrosis. Pediatr. Pulmonol., 1994, 18 : 150-4.
11. Navarro J., Munck A. : Perspectives d'utilisation de la rhDNase et thérapeutiques nouvelles de la mucoviscidose. Arch. Pédiatr., 1995, 2 : 682-4.
12. Mukhopadhyay S., Baer S., Blanshard J., Coleman M., Carswell F. : Assessment of potential ototoxicity following high-dose nebulized tobramycin in patients with cystic fibrosis. J. Antimicrob. Chemother., 1993, 31 : 429-436.
13. Laube B.L., Links J.M., Lafrance N.D., Wagner H.N., Rosenstein B.J. : Homogeneity of bronchopulmonary distribution of 99mTc aerosol in normal subjects and in cystic fibrosis patients. Chest, 1989, 95 : 822-30.
14. Mukhopadhyay S., Stadon G.E., Eastman C., Palmer M., Davies E.R., Carswell F. : The quantitative distribution of nebulized antibiotic in the lung of cystic fibrosis. Respiratory Medicine, 1994, 88 : 203-2117
15. Newman S.P. : Aerosol deposition considerations in inhalation therapy. Chest, 1985, 88 : 152S-159S.
16. Smith A.L., Ramsey B. : Aerosol administration of antibiotics. Respiration, 1995, 62 (Suppl I) : 19-24.
17. Fuchs H., Borowitz D., Christiansen D. et al. : The effect of aerosolized recombinant human DNase on respiratory exacerbations and pulmonary function in patients with cystic fibrosis. N. Eng. J. Med., 1994, 331 : 637-542.
18. Hodson M.E. : aerosolized dornase alfa for therapy of cystic fibrosis. Am. J. Respir. Crit. Care Med., 1995, 151 : S70-S74.
19. Di Sant'agnese P.A., Abderson D.A. : Celiac syndrome. Am. J. Dis. Child., 1946, 72 : 17-61.
20. Wall M.A., Terry A.B., Eisenberg J., Mac Namara M. : Inhaled antibiotics in cystic fibrosis. Lancet, 1983, i : 1325.
21. Kun P., Landau L.I., Phelan P.D.: Nebulized gentamicin in children and adolescents with cystic fibrosis. Aust. Paediatr. J., 1984, 20 : 43-5.
22. Carswell F., Ward C., Cook D.A., Speller D.C.E. : A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosis. Br. J. Dis. Chest, 1987, 81 : 356-360.
23. Jensen T., Pedersen S., Garne S., Heilman S., Hoiby N., Koch C. : Colistin inhalation therapy in cystic fibrosis patients with chronic pseudomonas aeruginosa lung infection. J. Antimicrobiol. Chemother., 1987, 19 : 831-8.
24. Stead R.J., Hodson M.E., Batten JC. : Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis with pseudomonas aeruginosa. Br. J. Dis. Chest, 1987, 81 : 272-9.
25. Gappa M., Steimkamp G., Tümmler B., Von Der Hardi H. : Long-term tobramycin aerosol therapy of chronic pseudomonas aeruginosa infection in patients with cystic fibrosis. Scand. J. Gastroenterol., 1988, 23 (suppl I) : 74-6.
26. Steinkamp G.S., Tümmler B., Gappa M. et al. : Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr. Pulmonol., 1989, 6 : 91-8.
27. Mac Lusky I., Gold R., Corey M., Levison H. : Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with pseudomonas aeruginosa. Pediatr. Pulmonol., 1989, 7 : 42-8.
28. Smith A.L., Ramsey B.W., Hedges D.L. et al. : Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis. Pediatr. Pulmonol., 1989, 7 : 265-271.
29. Ramsey B.W., Dorkin H.L., Eisenberg J.D. et al. : Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N. Eng. J. Med., 1993, 328 : 1740-6.
30. Stephens D., Garey N., Isles A., Levison H., Gold R. : Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis. Pediatr. Infect. Dis., 1983, 2 : 209-211.
31. Schaad U.B., Wedgwood-Kruck J., Suter S., Kraemer R. : Efficacy of inhaled amikacin as adjunct to intravenous, combination therapy (ceftazidime and amikacin) in cystic fibrosis. J. Pediatr., 1987, 111 : 599-605.
32. Cooper D.M., Harris M., Mitchell I. : Comparison of intravenous and inhalation antibiotic therapy in acute pulmonary deterioration in cystic fibrosis. Am. Rev. Respir. Dis., 1985, 131 : A242.
33. Littlewood J.M., Miller M.G., Ghoneim A.T., Ramsden C.H. : Nebulised colimycin for early pseudomonas colonisation in cystic fibrosis. Lancet, 1985, i : 865.
34. Valerius N.H., Koch C., Hoiby N. : Prevention of chronic pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet, 1991, ii : 725-6.
35. Vasquez C., Municio M., Corera M., Gaztelurrutia L., Sojo A., Vitoria J.C. : Early treatment of pseudomonas aeruginosa colonization in cystic fibrosis. Acta Paediatr., 1993, 82 : 308-9.
36. Mukhopadhyay S., Singh M., Cater D.L. et al. : Meta-analysis of nebulized antipseudomonal antibiotic therapy in cystic fibrosis. Thorax, 1996, 51 : 364-8.
37. Touw D.J., Brimicombe R.W., Hodson M.E., Heijerman H.G.M., Bakker W. : Inhalation of antibiotics in cystic fibrosis. Eur. Respir. J., 1995, 8 : 1594-1904.
38. Chua H.L., Collis G.G., Lesouëf P.N. : Bronchial response to nebulized antibiotics in children with cystic fibrosis. Eur. Respir. J., 1990, 3 : 1114-6.
39. Pavia D., Thompson M.L., Clarke S.W. : Inhanced clearance of secretions from the human lung after the administration of hypertonic aerosol. Am. Rev. Respir. Dis., 1978, 117 : 199-203.
40. Robinson M., Regnis J.A., Bailey D.L., King M, Bantovitch C.J., Bye P.T. : Effect of hypertonic saline, amiloride and cough on mucociliary clearance in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med., 1996, 153 : 1503-1509.
41. Eng P.A., Morton J., Douglas J.A., Riedler J., Wilson J., Robertson M. : Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr. Pulmonol., 1996, 21 : 77-83.
42. Kuhn R.J., Lubin A.H., Jones P.R., Nahata M.C. : Bacterial contamination of aerosol solutions used to treat cystic fibrosis. Am. J. Hospital. Pharm., 1982, 39 : 308-9.